Work

Bevacizumab Impact on Hearing Loss Due to Neurofibromatosis Type 2 Associated Vestibular Schwannomas and Associated Biomarkers (S34.004)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.86.16_supplement.s34.004

Authors: Jaishri Blakeley, Xiobu Ye, Gabriel Duda, Christopher Halpin, Amanda Bergner, Alona Muzikansky, Vanessa Merker, Elizabeth Gerstner, Laura Fayad, Shivani Ahlawat, Michael Jacobs, Rakesh Jain, Eva Dombi, Brigitte Widemann, Scott Plotkin

Institutions: Johns Hopkins University, Massachusetts General Hospital, Massachusetts Eye and Ear Infirmary, Johns Hopkins Medicine, National Cancer Institute, Center for Neuro-Oncology

Language: English

Topic: Neurofibromatosis and Schwannoma Cases

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554816926

FWCI:

Cites:

Cited by:

Related to: 10